Search results for "Highlights"


 
Results 21 - 30 of about 51 for "Highlights".

Keeping tabs

Highlights from the conference, held this past week in San Diego, included new research and clinical tips on stopping Barrett's esophagus surveillance, diet and environmental risk factors in patients with
May 2019

Highlights

There is no evidence that screening for pancreatic cancer or treating screen-detected disease improves disease-specific morbidity or all-cause mortality in average-risk adults with no symptoms, the U.S. Preventive Services Task Force (USPSTF)
August 2019

Efficacy, safety of second-line therapies analyzed for two types of IBS

A systematic review and network meta-analysis focused on alosetron, eluxadoline, ramosetron, and rifaximin in adult patients who had irritable bowel syndrome (IBS) with diarrhea or mixed stool.
April 2019

Highlights

The increase primarily occurred among people who reported drug use or homelessness.
May 2019

Guideline recommends standardized management of mild to moderate ulcerative colitis

The guideline focuses on oral and topical 5-aminosalicylic acid medications, rectal corticosteroids, and oral budesonide in patients with mild to moderate disease.
December 2018

Individual or group hypnotherapy associated with relief from IBS

Although hypnotherapy did not improve quality of life, psychological symptoms, cognition, self-efficacy, or irritable bowel syndrome (IBS) symptoms significantly more than an educational support program, it may provide relief to patients by changing
December 2018

Previous gastroenteritis may be associated with later risk for IBD

In this Swedish case-control study, any previous GI infection and previous bacterial, parasitic, and viral GI infection were associated with higher risk for inflammatory bowel disease (IBD) versus controls.
November 2018

Highlights

In a meta-analysis of 22 studies in patients with nonalcoholic fatty liver disease (NAFLD), weight loss interventions were associated with improvements in alanine aminotransferase level, liver steatosis, histologic NAFLD activity score, and
July 2019

Highlights

An accompanying editorial said that based on the risk of gastrointestinal (GI) events found in this retrospective study, sodium polystyrene sulfonate should not be used to reduce serum potassium levels.
June 2019

Highlights

There was no significant difference in upper GI events between a pantoprazole group and a placebo group, although pantoprazole was associated with significantly reduced bleeding of gastroduodenal lesions, an industry-funded study found.
May 2019

Result Page: Prev   1   2   3   4   5   Next